Daily Stock Opinions — Stockchase
WATCH LIST
Expand All

Latest Expert Opinions Stocks Market Too many ads? Remove ads !


Mastercard Inc.
COMMENT
Johnson & Johnson
BUY
Enbridge
DON'T BUY
Toronto Dominion
BUY
National Bank of Canada
DON'T BUY
New Flyer Industries Inc.
BUY
TFI International Inc
PARTIAL BUY

Page 3

Next page
Signal Opinion Expert
BUY
Suncor Energy Inc(SU-T) 

December 13, 2018

CNQ-T vs. SU-T. It depends on your appetite for volatility and your expectations for returns. CNQ-T is a bet on oil. SU-T is more defensive but with less upside if you get the timing right on the price of oil. SU-T has a good opportunity to step in.
integrated oils
0 0 0 0 0
0 comments
CNQ-T vs. SU-T. It depends on your appetite for volatility and your expectations for returns. CNQ-T is a bet on oil. SU-T is more defensive but with less upside if you get the timing right on the price of oil. SU-T has a good opportunity to step in.
integrated oils
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$40.960
Owned Owned
Unknown

COMMENT
CM-T vs. BNS-T. There is a divergence in the Canadian banks between revenues sources and price to earnings and dividend yield. CM-T is latest to get into the US and BNS-T was more focused on Latin America. These two are trading at the most attractive valuations. The lower valuation is justified. There is something to be said about the stability of the US revenues with other Canadian banks.
banks
0 0 0 0 0
0 comments
CM-T vs. BNS-T. There is a divergence in the Canadian banks between revenues sources and price to earnings and dividend yield. CM-T is latest to get into the US and BNS-T was more focused on Latin America. These two are trading at the most attractive valuations. The lower valuation is justified. There is something to be said about the stability of the US revenues with other Canadian banks.
banks
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$107.090
Owned Owned
Yes

COMMENT
Bank of Nova Scotia(BNS-T) 

December 13, 2018

CM-T vs. BNS-T. It depends on your appetite for volatility and your expectations for returns. CNQ-T is a bet on oil. SU-T is more defensive but with less upside if you get the timing right on the price of oil. SU-T has a good opportunity to step in.
banks
0 0 0 0 0
0 comments
CM-T vs. BNS-T. It depends on your appetite for volatility and your expectations for returns. CNQ-T is a bet on oil. SU-T is more defensive but with less upside if you get the timing right on the price of oil. SU-T has a good opportunity to step in.
banks
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$72.050
Owned Owned
Yes

WATCH
DineEquity(DIN-N) 

December 13, 2018

They had a real run and the stock got hammered. It had a sharp bounce off the bottom and is up 60% this year. It is hard to buy a company with this kind of run-up. You should have patience and look for a dip or a sell-off.
food services
0 0 0 0 0
0 comments
They had a real run and the stock got hammered. It had a sharp bounce off the bottom and is up 60% this year. It is hard to buy a company with this kind of run-up. You should have patience and look for a dip or a sell-off.
food services
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$85.000
Owned Owned
Unknown

TOP PICK
He wants liquidity to be able to take advantage of continued volatility going into 2019. This pays about 2% yield. Think of it as cash. It is an option to step in and do some buying later.
E.T.F.'s
0 0 0 0 0
0 comments
He wants liquidity to be able to take advantage of continued volatility going into 2019. This pays about 2% yield. Think of it as cash. It is an option to step in and do some buying later.
E.T.F.'s
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$83.260
Owned Owned
No

TOP PICK
Novo-Nordisk(NVO-N) 

December 13, 2018

Given that markets will be lack luster he is looking for defensive names. They are focused on the diabetes space. The disease is growing at double digit rates. With their economies of scale, their profit margin is higher than their competitors. The most significant growth in diabetes is in emerging markets where they pay for the drugs themselves. They have to be able to reduce their prices in these markets. (Analysts’ price target is $49.60)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Given that markets will be lack luster he is looking for defensive names. They are focused on the diabetes space. The disease is growing at double digit rates. With their economies of scale, their profit margin is higher than their competitors. The most significant growth in diabetes is in emerging markets where they pay for the drugs themselves. They have to be able to reduce their prices in these markets. (Analysts’ price target is $49.60)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$46.770
Owned Owned
Yes

TOP PICK
Open Text(OTEX-T) 

December 13, 2018

He is comfortable with their ability to integrate their acquisitions. They have a track record of their acquisitions having worked in the past. You get a reasonable dividend. It is a replacement for CSU-T. (Analysts’ price target is $55.92)
computer software/processing
0 0 0 0 0
0 comments
He is comfortable with their ability to integrate their acquisitions. They have a track record of their acquisitions having worked in the past. You get a reasonable dividend. It is a replacement for CSU-T. (Analysts’ price target is $55.92)
computer software/processing
0 0 0 0 0
0 comments
Kash Pashootan

CEO & Chie, First Avenue Investm...

Price Price
$45.200
Owned Owned
Yes

Showing 15 to 21 of 170,932 entries
TOP PICKS
 
Successfully Saved Company
Successfully Saved Company